Abstract
Breast cancer (BC) is a heterogeneous disease that can be triggered by genetic alterations in mammary epithelial cells, leading to diverse disease outcomes in individual patients. The metabolic heterogeneity of BC enhances its ability to adapt to changes in the tumor microenvironment and metabolic stress, but unfavorably affects the patient’s therapy response, prognosis and clinical effect. Extrinsic factors from the tumor microenvironment and the intrinsic parameters of cancer cells influence their mitochondrial functions, which consequently alter their lipid metabolism and their ability to proliferate, migrate and survive in a harsh environment. The balanced interplay between mitochondria and fatty acid synthesis or fatty acid oxidation has been attributed to a combination of environmental factors and to the genetic makeup, oncogenic signaling and activities of different transcription factors. Hence, understanding the mechanisms underlying lipid metabolic heterogeneity and alterations in BC is gaining interest as a major target for drug resistance. Here we review the major recent reports on lipid metabolism heterogeneity and bring to light knowledge on the functional contribution of diverse lipid metabolic pathways to breast tumorigenesis and therapy resistance.
Funder
National Fund for Scientific Research, NFSR/FNRS, Belgium
Reference128 articles.
1. Abdalla, F., Singh, B., and Bhat, H.K. (2020). MicroRNAs and Gene Regulation in Breast Cancer. J. Biochem. Mol. Toxicol., 34.
2. Gene Expressions and Their Significance in Organoid Cultures Obtained from Breast Cancer Patient-Derived Biopsies;Pranav;Acta Histochem.,2022
3. Molecular Subtypes and Local-Regional Control of Breast Cancer;Fragomeni;Surg. Oncol. Clin. N. Am.,2018
4. Heterogeneity in Breast Cancer;Polyak;J. Clin. Investig.,2011
5. HER2 Gene Status in Primary Breast Cancers and Matched Distant Metastases;Tapia;Breast Cancer Res.,2007
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献